Series D - Syapse

Series D - Syapse

Investment Firm

Overview

Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care

Announced Date

Nov 14, 2017

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Safeguard Scientifics

Safeguard Scientifics

Safeguard Scientifics is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

8

Investor Name
Participant InvestorAscension Ventures
Participant InvestorSafeguard Scientifics
Participant InvestorRoche Venture Fund
Participant InvestorMedidata
Participant InvestorSocial Capital

Round Details and Background

Syapse raised $30000000 on 2017-11-14 in Series D

Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 12, 2016
Series C - Syapse
3-25.0M
Jul 10, 2014
Series B - Syapse
2-10.0M
Jan 01, 2011
Angel Round - Syapse
-1.6M
Jan 22, 2013
Series A - Syapse
1-3.0M

Recent Activity

There is no recent news or activity for this profile.